Showing results (171-180 of 272) with videos related to

Sort By:
Pageof 28
RMD Open|January 10, 2024
Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohortMoritz Scheidegger, Marouane Boubaya, Alexandru Garaiman, et al.
Arthritis Research & Therapy|August 15, 2021
The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to casesYukai Wang, Shaoqi Chen, Shaoyu Zheng, et al.
The European Respiratory Journal|March 26, 2026
Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trialMarlies S Wijsenbeek, Shervin Assassi, Arata Azuma, et al.
Chest|October 16, 2022
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and ResearchAnna-Maria Hoffmann-Vold, Cathrine Brunborg, Paolo Airò, et al.
RMD Open|November 10, 2023
Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomesTea Gegenava, Federico Fortuni, Nina Marijn van Leeuwen, et al.
The Lancet. Rheumatology|January 27, 2024
Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort studyRucsandra Dobrota, Suzana Jordan, Pernille Juhl, et al.
The Journal of Antimicrobial Chemotherapy|October 2, 2018
Novel linezolid resistance plasmids in Enterococcus from food animals in the USAGregory H Tyson, Jonathan L Sabo, Maria Hoffmann, et al.
Swiss Medical Weekly|April 5, 2024
Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohortKevin Windirsch, Suzana Jordan, Mike Oliver Becker, et al.
Frontiers in Immunology|October 10, 2022
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertensionHenriette Didriksen, Øyvind Molberg, Adi Mehta, et al.
The European Respiratory Journal|February 22, 2020
Predictors of progression in systemic sclerosis patients with interstitial lung diseaseOliver Distler, Shervin Assassi, Vincent Cottin, et al.
Pageof 28